| Browse |
| Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants. |
| Lineage (WHO label)   | Target Gene | Primer Name | Primer Sequence | Primer Length | Primer GC Content (%) | Start Position | End Position | Primer Direction | ΔG (cal) | Primer first used |
|---|---|---|---|---|---|---|---|---|---|---|
| HK.16 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| P.7 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| AY.121.1 (Delta) | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| BQ.1.2 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.177.26 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| AY.4.10 (Delta) | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| BA.2.58 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| Q.6 (Alpha) | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.160.26 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.1.348 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.1.371 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.258.17 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| P.1.9 (Gamma) | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.165 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.444 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.1.74 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| AY.29.2 (Delta) | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| AY.134 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| FL.13.3.1 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.46 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| AY.79 (Delta) | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.160.27 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| B.1.177.68 | N | US-CDC-N-2 | GCGCGACATTCCGAAGAA | 18 | 55.56 | 29230 | 29213 | R | -1668.53 | US |
| AY.4.2.4 (Delta) | ORF1ab | Chan-ORF1ab | GTGTGATGTTGAWATGACATGGTC | 24 | 41.67 | 16353 | 16330 | R | -1676.89 | China |
| AY.79 (Delta) | ORF1ab | Chan-ORF1ab | GTGTGATGTTGAWATGACATGGTC | 24 | 41.67 | 16353 | 16330 | R | -1676.89 | China |
| B.1.208 | ORF1ab | Chan-ORF1ab | GTGTGATGTTGAWATGACATGGTC | 24 | 41.67 | 16353 | 16330 | R | -1676.89 | China |
| B.1.459 | ORF1ab | Chan-ORF1ab | GTGTGATGTTGAWATGACATGGTC | 24 | 41.67 | 16353 | 16330 | R | -1676.89 | China |
| B.1.1.523 | ORF1ab | Chan-ORF1ab | GTGTGATGTTGAWATGACATGGTC | 24 | 41.67 | 16353 | 16330 | R | -1676.89 | China |
| B.1.333 | ORF1ab | Chan-ORF1ab | GTGTGATGTTGAWATGACATGGTC | 24 | 41.67 | 16353 | 16330 | R | -1676.89 | China |
| AY.4.10 (Delta) | ORF1ab | Chan-ORF1ab | GTGTGATGTTGAWATGACATGGTC | 24 | 41.67 | 16353 | 16330 | R | -1676.89 | China |
| B.1.1.194 | ORF1ab | Chan-ORF1ab | GTGTGATGTTGAWATGACATGGTC | 24 | 41.67 | 16353 | 16330 | R | -1676.89 | China |
| B.1.494 | S | NIID WH-1 F24381R24873 | TCAAGACTCACTTTCTTCCAC | 21 | 42.86 | 24364 | 24384 | F | -1709.56 | Japan |
| B.1.277 | N | Young-N | CTCAGTCCAAGATGGTATTTCT | 22 | 40.91 | 28583 | 28604 | F | -1711.48 | Singapore |
| BE.1.1.2 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| BF.7 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| BA.5.5.1 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| BQ.1.1.19 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| BQ.1.1 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| BA.5 (Omicron) | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| BA.5.2.1 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| unclassifiable | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| FL.13.3.1 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| CM.8.1.2 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| XBB.1.11.1 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1717.06 | France |
| B.1.1.516 | ORF1ab | Pasteur-ORF1ab-1 | CTCCCTTTGTTGTGTTGT | 18 | 44.44 | 12797 | 12780 | R | -1740.61 | France |
| B.1.287 | S | NIID WH-1 Seq F24383R24865 | CAAAGACACCTTCACGAGG | 19 | 52.63 | 24848 | 24830 | R | -1751.85 | Japan |
| B.1.1.391 | ORF1ab | Pasteur-ORF1ab-1 | ATGAGCTTAGTCCTGTTG | 18 | 44.44 | 12690 | 12707 | F | -1779.15 | France |
| GN.3 | N | NIH-TH_N | CCCCACTGCGTTCTCCATT | 19 | 57.89 | 28376 | 28358 | R | -1801.38 | Thailand |
| N.8 | N | HKU-N | TAATCAGACAAGGAACTGATTA | 22 | 31.82 | 29145 | 29166 | F | -1811.5 | Hong Kong |
| BQ.1.1.19 | ORF1ab | Won-ORF1ab | TGCATTAACATTGGCCGTGA | 20 | 45 | 15558 | 15539 | R | -1845.14 | South Korea |
| Lineage (WHO label) | Target Gene | Primer Name | Primer Sequence | Primer Length | Primer GC Content (%) | Start Position | End Position | Primer Direction | ΔG (cal) | Primer first used |